Callan JMB Inc

CJMB

Market cap $8.07M

Agreement reinforces the Atlas Complex strategy while expanding Callan JMB's recurring infrastructure services business through a 60% participation in enterprise revenue. The enterprise's underlying business plan contemplates annual revenue of between $12 million and $25 million within seven years under its base-case scenario.

This new landmark project is forecast to ultimately generate estimated annual gross revenues of $500 million for the partnership Callan JMB is entitled to receive a 21% participation in the venture, which could represent approximately $105 million in revenue for the first year and over $400 million in revenues over the five-year agreement The next phase of the project is being initiated with the development of the Marion 9 Biomanufacturing Center at the Atlas Complex by Callan JMB in Marion, Alabama MARION, Ala., July 29, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced breaking ground at the Atlas Complex representing the completion of an important strategic partnership with Alabama State University (“ASU”) to support the development of a significant integrated pharmaceutical manufacturing ecosystem designed to strengthen the United States (U.S.) domestic pharmaceutical production, enhance U.S. supply chain resilience, and improve national medical preparedness.

Management believes the initiative could represent a potential $414 million five-year revenue opportunity for Callan JMB while helping establish a next-generation pharmaceutical manufacturing ecosystem in the United States.

Strategic partnership integrates higher education, industry, and workforce development to accelerate pharmaceutical onshoring and strengthen domestic supply chains

Approval enhances the Company's ability to receive, prepare, and deploy pediatric-focused medical materials in support of state and local public health initiatives

Strategic extension reinforces recurring revenue visibility and growing demand for preparedness, continuity, and cold chain infrastructure Spring Branch, TX, May 20, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced the expansion and extension of an existing long-term public sector infrastructure engagement valued at approximately $175,000 per month over the next six months. The agreement represents approximately $1.05 million in projected recurring revenue over the next six months, tied to continued operational support, specialized storage, preparedness operations, monitoring, and mission-critical logistics services under an active governmental infrastructure initiative.

Spring Branch, TX, April 17, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today issued a statement in response to a recently filed lawsuit in the U.S. District Court for the Northern District of Texas.

Reverse Distribution Coordination Delivered Necessary Medical Supplies to Requesting Jurisdictions through its Established Emergency Preparedness Network

Independent oversight reinforces manufacturing, supply chain integrity, and federal readiness for a platform designed to scale across multiple indications

Callan JMB Inc. (CJMB) Presents at IAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 Transcript